Alpha9Alpha10 Nicotinic Acetylcholine Receptors as Target for the Treatment of Chronic Pain

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|38|6042-6047

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.38, 2014-11, pp. : 6042-6047

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alpha7 neuronal nicotinic receptors as a drug target in schizophrenia

By Wallace Tanya L.   Bertrand Daniel  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 2, 2013-02 ,pp. : 139-155

Informa Healthcare

Access to resources Recommend Favorite

Targeting the α9α10 nicotinic acetylcholine receptor to treat severe pain

By Vincler Michelle   McIntosh J Michael  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 7, 2007-07 ,pp. : 891-897

Informa Healthcare

Access to resources Recommend Favorite

Nicotinic Receptors and the Treatment of Attentional and Cognitive Deficits in Neuropsychiatric Disorders: Focus on the 7 Nicotinic Acetylcholine Receptor as a Promising Drug Target for Schizophrenia

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 7, Iss. 4, 2007-12 ,pp. : 269-288

Bentham Science Publishers

Access to resources Recommend Favorite

α7 Nicotinic Acetylcholine Receptors: A Therapeutic Target in the Structure Era

By  

Current Drug Targets, Vol. 13, Iss. 5, 2012-01 ,pp. : 695-706

Bentham Science Publishers

Access to resources Recommend Favorite

Nicotinic Acetylcholine Receptors and Epilepsy

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 1, Iss. 4, 2002-08 ,pp. : 443-448

Bentham Science Publishers

Access to resources Recommend Favorite